From: Management of non-ovarian cancer malignant ascites through indwelling catheter drainage
Variables | Overall Survival | SP Survival | ||
---|---|---|---|---|
p | Hazard Ratio(95 % CI) | p | Hazard Ratio(95 % CI) | |
Age | 0.681 | Â | 0.656 | Â |
 <=50 | Ref |  | Ref | Ref |
 50–70 | 0.575 | 1.211 (0.621–2.361) | 0.360 | 1.357(0.707–2.604) |
 > = 70 | 0.744 | 0.858 (0.344–2.140) | 0.617 | 1.246(0.526–2.950) |
Gender(male/female) | 0.323 | 1.339 (0.750–2.392) | 0.667 | 0.877(0.484–1.591) |
Primary cancer | 0.026* | Â | 0.315 | Â |
 GI group | Ref | Ref | Ref | Ref |
 Others | 0.03 | 0.418 (0.190–0.920) | 0.561 | 0.805(0.388–1.672) |
 Unknown | 0.033 | 0.423 (0.192–0.932) | 0.134 | 0.566(0.268–1.192) |
Ascites related | Â | Â | Â | Â |
 Color | 0.566 |  | 0.693 |  |
 Yellow | Ref | Ref | Ref | Ref |
 Brown | 0.291 | 1.571 (0.680–3.630) | 0.543 | 0.779(0.348–1.742) |
 Red | 0.656 | 1.167 (0.591–2.304) | 0.830 | 1.074(0.561–2.054) |
 LDH (>200/<=200) | 0.225 | 0.798 (0.442–2.350) | 0.065 | 0.520(0.275–0.984) |
Rivalta Test | 0.077 | Â | 0.745 | Â |
 - | Ref | Ref | Ref | Ref |
 + | 0.067 | 0.258 (0.096–0.695) | 0.453 | 1.418(0.570–3.530) |
 ++ − +++ | 0.088 | 0.357 (0.141–0.902) | 0.507 | 1.321(0.581–3.003) |
 Gravity (>1.012/<=1.012) | 0.260 | 0.706 (0.385–1.294) | 0.159 | 0.649(0.356–1.185) |
Volume removed | 0.904 | Â | 0.357 | Â |
 <=3000 ml | Ref | Ref | Ref | Ref |
 3000–5000 ml | 0.701 | 1.161 (0.542–2.484) | 0.873 | 0.939(0.433–2.035) |
 > = 5000 ml | 0.961 | 0.985 (0.537–1.806) | 0.249 | 1.494(0.755–2.958) |
 Serum albumin (<30 g/L/> = 30 g/L) | 0.394 | 0.759 (0.402–1.432) | <0.001* | 0.258(0.128–0.517) |